Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrauterine Misoprostol + Oxytocin vs Oxytocin for PPH Prevention
NCT04724187Phase 2Unknown
- Sponsor
- Islamabad Medical and Dental College
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of misoprostol in postpartum hemorrhage (PPH) (2 arms), sponsored by Islamabad Medical and Dental College. Primary endpoint: measurement of haemoglobin level to assess the blood loss at 6 months. Status: unknown.
02
Drugs
misoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT04724187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04724187.